The U.S. Food and Drug Administration (FDA) today authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, without convening its vaccine advisory panel of independent experts to discuss Pfizer’s data on 5- to 11-year-olds — and based on a study subset of only 67 children, CNBC reported.
"I've heard people say it's common sense (to get vaccinated), but what about all the other countries that have taken it and still put people in lockdown," says local Ghanaian.
Disney is reportedly planning to curtail the types of advertisements available on a new tier of its streaming service to keep the environment “family-friendly,” according to Variety.
The U.S. Food and Drug Administration on Tuesday authorized the use of a booster shot of Pfizer (PFE.N) and BioNTech's COVID-19 vaccine for children aged 5 to 11, making everyone in the country over the age of 5 eligible for a third shot.